Dysregulation of TRPM3 interferes with intracellular Ca2+ mobilization and consequently affects intracellular signaling pathways, which has previously been demonstrated in NK cells from ME/CFS patients (31, 34, 48, 49). This evidence concerns the gene TRPM3 and myalgic encephalomeyelitis/chronic fatigue syndrome.